1 results match your criteria: "The First Medical Center Chinese People's Liberation Army General Hospital Beijing China.[Affiliation]"
Leukocyte immunoglobulin-like receptor B4: A keystone in immune modulation and therapeutic target in cancer and beyond.
Cancer Innov
December 2024
Faculty of Hepato-Pancreato-Biliary Surgery, The First Medical Center Chinese People's Liberation Army General Hospital Beijing China.
Article Synopsis
- LILRB4 plays a crucial role in regulating immune responses and is linked to the development and progression of various cancers, including leukemia and solid tumors.
- The review covers LILRB4's structural features, expression in different immune cells, and its ability to either enhance or inhibit immune functions.
- Current research also explores advanced therapeutic approaches targeting LILRB4, emphasizing its potential as a key target for cancer treatment and other health conditions.